FDA Inspection — Quality System Architecture Explanation

Organization: Sawgrass Nutra Labs (SNL)
Regulatory Scope: 21 CFR Part 111 (Dietary Supplements)


Purpose of This Explanation

This document provides a concise explanation of how Sawgrass Nutra Labs has structured its Quality Management System (QMS) to meet the requirements of 21 CFR Part 111, with specific focus on:

This document is informational only and does not establish or modify controlled procedures or governance requirements.


Quality Unit Structure

Sawgrass Nutra Labs operates under a single, independent Quality Unit, referred to internally as Quality Control Operations (QCO).

In accordance with 21 CFR 111 Subpart F, the Quality Unit retains non-delegable responsibility and authority for all quality-impacting decisions.

This includes, but is not limited to:

The Quality Unit operates independently from Manufacturing, Packaging, Warehouse, and Supply Chain functions.


Separation of Governance, Control, and Execution

The QMS is intentionally structured into distinct layers to ensure independence, consistency, and regulatory compliance:

Execution of activities does not transfer Quality Control decision authority.


Process Family Pack Model

Operational controls are organized into Process Family Packs (e.g., Warehouse, Production, Packaging).

Each Family Pack is a controlled SOP bundle that includes:

Family Packs inherit Quality Control authority explicitly and do not redefine or dilute Quality Unit decision rights.


Quality Control Authority Inheritance

Every Process Family Pack includes a Quality Control Authority & Governance Inheritance statement establishing that:


Execution by Non-Quality Functions

Certain quality-governed activities (e.g., receiving checks, environmental monitoring, material handling) may be executed by trained personnel outside the Quality Unit.

For regulatory purposes:

This execution model is consistent with FDA expectations and industry practice.


Records and Evidence

Execution of activities generates controlled Auditable Artifacts that:

Records demonstrate execution; authority remains with the Quality Unit.


Summary for FDA Investigators

If asked, “Who makes the quality decision?” — the answer is always: Quality Control.


This document is an inspection-support explanation and does not replace controlled QMS governance, SOPs, or records.